DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine

Proceedings of the Western Pharmacology Society

Volumn 40, Issue , 1997, Pages 9-12

  Fretland Yifeng, Adrian J ^a   Hein, David W ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ACYLTRANSFERASE; CYTOCHROME P450;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DNA ADDUCT; DRUG ACETYLATION; GENETIC POLYMORPHISM; GENOTYPE; HYDROXYLATION; MALE; NONHUMAN; RAT; TISSUE DISTRIBUTION;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS, ENVIRONMENTAL; DEOXYGUANOSINE; DNA ADDUCTS; IMIDAZOLES; MALE; MUTAGENS; PHENOTYPE; POLYMORPHISM, GENETIC; RATS; RATS, INBRED F344; RATS, INBRED WKY; TISSUE DISTRIBUTION;

EID: 0030699060     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hein, DW: Biochim Biophys Acta 948:37 (1988).
2. Grant DM: Pharmacogenetics 3:45 (1993).
3. Vatsis KP, Weber WW, Bell DA, Dupret J-M, Evans DAP,. Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T & Yamazoe Y: Pharmacogenetics 5:1 (1995).
4. Hein DW, Rustan TD, Bûcher KD, Furman EF & Martin WJ: J Pharmacol Exp Ther 258:232 (1991).
5. Hein DW, Rustan TD, Bûcher KD, Martin WJ & Furman EJ: Drug Metab Dispos 19:933 (1991).
6. Juberg DR, Bond JT & Weber WW: Pharmacogenetics 1:50 (1991).
7. Doll MA & Hein DW: Pharmacogenetics 5:247 (1995).
8. Hein DW, Doll MA, Fretland AJ, Gray K, Deitz AC, Feng Y. Jiang W. Rustan TD & Wilkie TR: Mutât Res, in press (1997).
9. Risch A, Wallace DMA, Bathers S & Sim E: Hum Mol Genet 4:231 (1995).
10. Roberts-Thomson 1C, Ryan P. Khoo KK,Hart WJ, McMichael AJ & Butler RH: Lancet 347:1372 (1996).
11. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Bauer S, Loddenkemper R & Roots I: Cancer Res 56:3961 (1996).
12. Ambrosone CB, Freudenheim JL, Graham S. Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM & Shields PG: JAMA 276:1494 (1996).
13. Jiang W, Doll MA & Hein DW: Proc North Dakota Acad Sei 50:24 (1996).
14. Layton DW, Bogen KT, Knize MK, Hatch FT, Johnson VM & Felton JS: Carcinogenesis 16:39 (1995).
15. Ushiyama H, Wakabayashi K, Hirose H, Itoh H, Sugimura T & Nagao M: Carcinogenesis 12:1417 (1991).
16. Lynch AM, Knize MG, Boobis AR, Gooderham JH, Davies DS & Murray S: Cancer Res 52:6216 (1992).
17. Manabe S, Tohyama K, Wada 0 & Aramaki T: Carcinogenesis 12:1945(1991).
18. Peluso M, Castegnaro M, Malaveille C, Friesen M, Garren L, Hautefeville A, Vincis P, Kadlubar F & Bartsch H: Carcinogenesis 12:713 (1991).
19. Doll R & Peto R: J Natl Cancer Inst 66:1191 (1981).
20. Gordon T, Kagan A, Garcia-Palmieri M, Kännel W8, Zukel WJ, Tillotson T, Sorlie P & Hjortland M: Circulation 63:500 (1981).
21. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S & SagimuraT: Carcinogenesis 12:1503 (1991).
22. Hasegawa R, Sano M, Tamano S, Imaida K, Shirai T, Nagao M, Sugimura T & Ito N: Carcinogenesis 14:2553 (1993).
23. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T & Ito N: Cancer Res 57:195 (1997).
24. Davis CD, Färb A, Thorgeirsson SS, Virmani R & Snyderwine KG: Toxicol Appl Pharmacol 124:201 (1994).
25. Takahashi S, Imaida K, Shirai T, Wakabayashi K, Nagao M, Sugimura T & Ito N: Toxicol Path 24:273 (1996).
26. Davis CD & Snyderwine KG: Fd Chem Toxic 33:641 (1995).
27. Kaderlik KR, Minchin RF, Mulder GJ, Ilett KF, DaugaardJenson M, Teitel CH & Kadlubar FF: Carcinogenesis 15:1703 (1994).
28. Dragsted LO, Frandsen H, Reistad R, Alexander J & Larson JC: Carcinogenesis 16:2785 (1995).
29. Lynch AM, Murray S, DelaTorre R, Solons A, Farre M, Segura J, Gooderham NJ & Davies DS: Cancer Res 54:89 (1994).
30. Minchin RF, Reeves PT, Teidel CH, McManus ME, Mojarabbi B, Ilett KF & Kadlubar FF: Biochem Biophys Res Commun 185:839 (1992).
31. Hein DW, Rustan TD, Ferguson RJ, Doll MA & Gray K: Arch Toxicol 68:129 (1994).
32. Feng Y, Jiang W & Hein DW: Toxicol Appl Pharmacol 141:2348 (1996).
33. Peluso M, Castagnara M, Malaveille C, Friesen M, Garren L, Hautefeuille A, Vineis P, Kadlubar F & Bartsch H: Carcinogenesis 12:713(1991).
34. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ & Grant DM: Carcinogenesis 14:1633 (1993).